404
Cytomegalovirus Infection Market Report
Global Cytomegalovirus Infection Market, Dynamics, Market Analysis
The report on Global Cytomegalovirus Infection Market is segmented By Drug Type (Cidofovir, Foscarnet, Valganciclovir, Ganciclovir), By Infection Type (Retinitis, Pneumonia, Gastrointestinal Ulcers, Encephalitis, Others), By Distribution Channel ...
The cytomegalovirus infection market size is expected to reach USD 751.2 million in the foreseeable future.
ViroPharma (The US), Chimerix, Inc. (The US), Vical, Inc. (The US), AiCuris Anti-infective Cures GmbH (Germany), Merck & Co., Inc. (The US), GlaxoSmithKline plc (UK), F. Hoffmann-La Roche AG (Switzerland), Clinigen Group PLC (UK), Fresenius Kabi Canada (Canada), Genentech Inc. (The US), and Gilead Sciences (The US) are among the key players in the cytomegalovirus infection market.
The cytomegalovirus infection market is expected to grow at an impressive growth of 6.3% CAGR in the coming years.
Growing awareness among the public related to herpes virus infection, increasing awareness associated with rare diseases, high purchasing power, improving healthcare infrastructure, and government support for novel treatment against rare genetic diseases are the factors driving the growth of cytomegalovirus infection market.
North American market garnered the largest market share in 2020 and is likely to register a considerable CAGR during the review period.
The ganciclovir segment held the highest share in 2020 and is likely to register a healthy CAGR during the review period.
Cytomegalovirus Infection treatment companies, Hospitals, Diagnostic Centers And Laboratories, Academic Institutions, Research Centers & Organizations are the target audience in the cytomegalovirus infection market.